作者:Kokkosi, Afroditi、Garofallidou, Elpida、Zacharopoulos, Nikolaos、Tsoureas, Nikolaos、Diamanti, Konstantina、Thomaidis, Nikolaos S.、Cheilari, Antigoni、Machalia, Christina、Emmanouilidou, Evangelia、Philippopoulos, Athanassios I.
DOI:10.3390/molecules29133215
日期:——
Organometallic complexes of the formula [Ru(N^N)(p-cymene)Cl][X] (N^N = bidentate polypyridyl ligands, p-cymene = 1-methyl-4-(1-methylethyl)-benzene, X = counter anion), are currently studied as possible candidates for the potential treatment of cancer. Searching for new organometallic compounds with good to moderate cytotoxic activities, a series of mononuclear water-soluble ruthenium(II)–arene complexes incorporating
有机金属络合物,结构式为 [Ru(N^N)(p-伞花烃)Cl][X](N^N = 二齿多吡啶基配体,p-伞花烃 = 1-甲基-4-(1-甲基乙基)-苯,X =反阴离子),目前正在研究作为潜在的癌症治疗的可能候选者。寻找具有良好至中等细胞毒性活性的新型有机金属化合物,一系列单核水溶性钌(II)-芳烃配合物,包含取代的吡啶-喹啉配体,在4位上带有未决的-CH2OH、-CO2H和-CO2Me基团首次合成了喹啉环,以研究它们对调节钌对伞花烃络合物活性的可能影响。这些包括 [Ru(η6-p-伞花烯)(pqhyme)Cl][X] (X = Cl− (1-Cl), PF6− (1-PF6), pqhyme = 4-羟甲基-2-(吡啶- 2-基)喹啉)、[Ru(η6-对伞花烃)(pqca)Cl][Cl] ((2-Cl)、pqca = 4-羧基-2-(吡啶-2-基)喹啉),和[Ru(η6-p-伞花烃)(pqcame)Cl][X]